[HTML][HTML] Review on Prevalence, Risk Factors, and Research Advancements on the Use of Medical Gloves Concerning Hand Dermatitis Among Health Care Workers
J Gunasegaran, YY Teh, CK Lim, SF Ng - Safety and Health at Work, 2024 - Elsevier
The COVID-19 pandemic has led to a significant surge in glove usage, as recommended by
the World Health Organization. Despite efforts to ensure the quality and safety of gloves …
the World Health Organization. Despite efforts to ensure the quality and safety of gloves …
Box–behnken design based optimized Quercetin nano formulation for palliative treatment of atopic dermatitis
A Singh, A Biswas, M Choudhari, S Roy… - Journal of Drug Delivery …, 2024 - Elsevier
Atopic dermatitis (AD) is a persistent, pruritic dermatosis impairing the lives of nearly fifteen
to thirty percent of children and ten percent of adults [1]. AD profoundly impairs patients' lives …
to thirty percent of children and ten percent of adults [1]. AD profoundly impairs patients' lives …
[PDF][PDF] 纳米药物在缺血性脑卒中靶向治疗中的研究进展
张敏娜， 唐仁明， 袁丽丽， 钟鸣… - 中国药理学与毒理学 …, 2023 - cjpt.magtechjournal.com
在缺血性脑卒中(IS) 发生过程中, 血管系统血栓可导致脑组织缺血缺氧, 产生炎症细胞因子引发
脑组织损伤, 缺血再灌注过程活性氧进一步引起应激性损伤. 常规给药受制于血脑屏障的选择性 …
脑组织损伤, 缺血再灌注过程活性氧进一步引起应激性损伤. 常规给药受制于血脑屏障的选择性 …
Crisaborole-Enthused Glycerosomal Gel for an Augmented Skin Permeation
R Singh, A Singh, D Srivastava… - Recent Advances in …, 2024 - benthamdirect.com
Background: Crisaborole (CB), a boron-based compound, is the first topical PDE4 inhibitor
to be approved by the US Food and Drug Administration (2016) for the treatment of Atopic …
to be approved by the US Food and Drug Administration (2016) for the treatment of Atopic …
Harnessing the Targeting Potential of Nano-biomaterials to Treat Autoimmune Skin Disorders
SPE Gnanakani, JJ Kirubakaran, P Rama… - … for Targeted Therapies, 2024 - Springer
Autoimmune skin disorders (AISD) stem from immune system malfunction, causing diseases
like psoriasis and vitiligo. Current treatments pose challenges due to side effects and skin …
like psoriasis and vitiligo. Current treatments pose challenges due to side effects and skin …
A REVIEW ON NOVEL NANOEMULGEL FOR OCULAR DRUG DELIVERY
N Chauhan, N Gupta, A Kumar - … Journal of Medical and Health Science, 2024 - eijmhs.com
Nanotechnology has been widely used the recent clinical trends, it enhances the potential of
the delivery of the drug in ocular target site by reducing complete and partial side effects …
the delivery of the drug in ocular target site by reducing complete and partial side effects …